The Optometric Glaucoma Society is pleased to announce the establishment of the Optometric Glaucoma Foundation (OGF).
Glaucoma affects more than 80 million individuals worldwide, damages the optic nerve leading to the loss of vision and, if not controlled, leads to blindness. Glaucoma affects more than 2.5 million Americans over the age of forty, with prevalence doubling over the next few decades; approximately one half of these individuals are undiagnosed. Optometrists, being primary eye care providers, are well positioned to have an important role in preventing visual impairment from glaucoma.
The mission of the OGF is to support glaucoma education for the optometric profession. This would include supporting educational programs for students, residents, educators and practitioners. The OGF will also promote excellence in the care of patients with glaucoma, support glaucoma research and provide the underpinnings to allow optometrists to be involved in research. This will require the cooperation between optometrists, ophthalmologists, scientists, educators, industry members, and patients, to achieve success.
The OGF is led by Dr. Murray Fingeret, President; Dr. Leo Semes, Vice President; Dr. John McSoley, Secretary; and Dr. Austin Lifferth, Treasurer. The Board of Directors includes Dr. John Flanagan, Dr. Peter Lalle, Dr. Tom Lewis, Dr. Brian Mahoney, Dr. Ron Melton, Dr. Leslie O’Dell, Dr. Denise Pensyl, and Dr. Robert Prouty. The Optometric Glaucoma Foundation is a 501(c)3 not-for-profit organization.